Literature DB >> 17823202

Paraquat induces dopaminergic dysfunction and proteasome impairment in DJ-1-deficient mice.

Wonsuk Yang1, Linan Chen, Yunmin Ding, Xiaoxi Zhuang, Un Jung Kang.   

Abstract

Parkinson's disease (PD) may be caused by a complex interaction of environmental insults and genetic susceptibilities. Previous studies of DJ-1-deficient mice have noted dopaminergic dysfunction mainly in older mice. To simulate the interaction of genetic factors and environmental factors, we treated DJ-1-deficient mice with paraquat. Even in relatively young mice, this combination produced dopamine loss and motor dysfunction. To determine the potential mechanism for the dopaminergic dysfunction, we investigated the proteasome function and ubiquitinated protein levels. DJ-1-deficient mice treated with paraquat showed decreased proteasome activities and increased ubiquitinated protein levels. To further investigate the mechanism of proteasome dysfunction, ATP levels and subunit protein levels of 19S ATPase Rpt6 and 20S beta5 were measured and noted to be decreased in the ventral midbrain, but not in the striatum. Finally, a transcription factor, Nrf2 that has been previously shown to be regulated by DJ-1 and to regulate 20S beta5 levels was decreased. These pathologies were not observed in brain regions of normal mice treated with paraquat. In conclusion, this study raises the possibility that environmental and genetic factors might cooperatively involve the mechanisms underlying proteasome impairment in PD brains.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823202     DOI: 10.1093/hmg/ddm249

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  38 in total

1.  Keap1-Nrf2 activation in the presence and absence of DJ-1.

Authors:  Li Gan; Delinda A Johnson; Jeffrey A Johnson
Journal:  Eur J Neurosci       Date:  2010-03-03       Impact factor: 3.386

Review 2.  Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.

Authors:  Rebecca Banerjee; Anatoly A Starkov; M Flint Beal; Bobby Thomas
Journal:  Biochim Biophys Acta       Date:  2008-11-14

3.  Mitochondrial therapies for Parkinson's disease.

Authors:  Bobby Thomas; M Flint Beal
Journal:  Mov Disord       Date:  2010       Impact factor: 10.338

Review 4.  The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson's disease.

Authors:  Yan Shen; Xingfang Guo; Chao Han; Fang Wan; Kai Ma; Shiyi Guo; Luxi Wang; Yun Xia; Ling Liu; Zhicheng Lin; Jinsha Huang; Nian Xiong; Tao Wang
Journal:  Cell Mol Life Sci       Date:  2017-06-16       Impact factor: 9.261

5.  DJ-1 deficient mice demonstrate similar vulnerability to pathogenic Ala53Thr human alpha-syn toxicity.

Authors:  Chenere P Ramsey; Elpida Tsika; Harry Ischiropoulos; Benoit I Giasson
Journal:  Hum Mol Genet       Date:  2010-01-20       Impact factor: 6.150

6.  The E163K DJ-1 mutant shows specific antioxidant deficiency.

Authors:  Chenere P Ramsey; Benoit I Giasson
Journal:  Brain Res       Date:  2008-09-16       Impact factor: 3.252

7.  Yeast polyubiquitin gene UBI4 deficiency leads to early induction of apoptosis and shortened replicative lifespan.

Authors:  Wei Zhao; Tao Zhou; Hua-Zhen Zheng; Kun-Pei Qiu; Hong-Jing Cui; Hui Yu; Xin-Guang Liu
Journal:  Cell Stress Chaperones       Date:  2017-11-07       Impact factor: 3.667

8.  DJ-1 mRNA anatomical localization and cell type identification in the mouse brain.

Authors:  Zhiguo Xie; Xiaoxi Zhuang; Linan Chen
Journal:  Neurosci Lett       Date:  2009-09-17       Impact factor: 3.046

Review 9.  Animal models of Parkinson's disease progression.

Authors:  Gloria E Meredith; Patricia K Sonsalla; Marie-Francoise Chesselet
Journal:  Acta Neuropathol       Date:  2008-02-14       Impact factor: 17.088

Review 10.  Mitochondrial control of cell bioenergetics in Parkinson's disease.

Authors:  Raquel Requejo-Aguilar; Juan P Bolaños
Journal:  Free Radic Biol Med       Date:  2016-04-16       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.